Announcement
14 Aug 2024
In August 2024, the National Bank for Economic and Social Development of Brazil (BNDES in Portuguese) approved loans with EMS Farmacêutica, Aché Laboratórios Farmacêuticos and Eurofarma Laboratórios SA.
Source
Number of interventions
6
6 certainly harmful
0 likely harmful
0 liberalising
Implementation date
14 Aug 2024
Revocation date:
No revocation date
The BNDES More Innovation credit line is subject to local content incentives. As such, so is the BRL 500 million (USD 91.6 million) loan to Eurofarma Laboratórios SA, granted on 14 August ...
On 14 August 2024, the National Bank for Economic and Social Development of Brazil (BNDES in Portuguese) and Eurofarma Laboratórios SA signed a BRL 500 million (USD 91.6 million) loan. The...
The BNDES More Innovation credit line is subject to local content incentives. As such, so is the BRL 389.7 million (USD 71.4 million) loan to Aché Laboratórios Farmacêuticos, granted on 14...
On 14 August 2024, the National Bank for Economic and Social Development of Brazil (BNDES in Portuguese) and Aché Laboratórios Farmacêuticos signed a BRL 389.7 million (USD 71.4 million) l...
The BNDES More Innovation credit line is subject to local content incentives. As such, so is the BRL 500 million (USD 91.6 million) loan to EMS, granted on 14 August 2024 by the National Bank for E...
On 14 August 2024, the National Bank for Economic and Social Development of Brazil (BNDES in Portuguese) and EMS Farmacêutica signed a BRL 500 million (USD 91.6 million) loan. The loan wil...
See all
This state act is not part of any Thread yet.